90%Confidence
0Views
FDASource
2026-03-02Date
Summary
Asteria Health faces a Class II recall for testosterone pellets due to potential metal particulate contamination, indicating serious manufacturing quality control failures. This poses significant patient safety risks and regulatory scrutiny, likely damaging the brand's reputation and potentially leading to financial penalties.
Actionable: Monitor Asteria Health for potential regulatory actions, supply chain disruptions, and consider reviewing investment exposure to compounding pharmacies with quality issues.
AI Confidence: 90%
Data Points
firmF.H. INVESTMENTS, Inc. (dba Asteria Health)
classificationClass II
statusOngoing
distributionNationwide in the USA
productTestosterone, 100 mg, 1 Sterile Pellet, Asteria Health 432 Industrial Ln, Birmingham, AL 35211, NDC:79559-1100-32.
Get Signals Instantly
Premium subscribers receive every signal via Telegram the moment it fires — hours before it appears here.
Subscribe Now